Genz-682452-AA ( DrugBank: GENZ-682452 )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	2

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-005324-41-GB (EUCTR)	07/10/2014	30/06/2014	Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ402671 in Tre ...	A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy ...	Fabry disease MedDRA version: 17.0;Level: PT;Classification code 10016016;Term: Fabry's disease;Syst ...	Product Code: GZ402671 / SAR402671 Other descriptive name: Genz-682452-AA Product Code: GZ402671 / SAR ...	Genzyme Corporation	NULL	Not Recruiting			Female: no Male: yes	8	Phase 2	France;United States;Czech Republic;Poland;Russian Federation;United Kingdom
2	EUCTR2013-005324-41-CZ (EUCTR)	19/09/2014	03/07/2014	Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ402671 in Tre ...	A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy ...	Fabry disease MedDRA version: 17.1;Level: PT;Classification code 10016016;Term: Fabry's disease;Syst ...	Product Code: GZ402671 / SAR402671 Other descriptive name: Genz-682452-AA Product Code: GZ402671 / SAR ...	Genzyme Corporation	NULL	Not Recruiting			Female: no Male: yes	8	Phase 2	France;United States;Czech Republic;Poland;Russian Federation;United Kingdom

First Previous1Next Last